In Other News

• Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

• Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy

• Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

• Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

• Drones Take Flight for Faster Blood Sample Delivery

• Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy

• Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability

• “Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies

• “Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies

• Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis

• Two-in-One DNA Analysis Improves Diagnostic Accuracy While Saving Time and Costs

• New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

• Newly-Identified Parkinson’s Biomarkers to Enable Early Diagnosis Via Blood Tests

• Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

• New Blood Test Could Detect Pancreatic Cancer at More Treatable Stage

• Automated Mass Spectrometry Set to Transform Routine Lab Testing

• AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America

• First-Of-Its-Kind Test Identifies Autism Risk at Birth

• New Tool Maps Chromosome Shifts in Cancer Cells to Predict Tumor Evolution

• World's First Blood Test Distinguishes Between Benign and Cancerous Lung Nodules

• Robotic Technology Unveiled for Automated Diagnostic Blood Draws

• First-Of-Its-Kind Test Identifies Autism Risk at Birth

• World's First Blood Test Distinguishes Between Benign and Cancerous Lung Nodules